Ozone IV Therapy — What It Is, Who Uses It, and What the Evidence Says

Ozone therapy is one of the more controversial protocols in integrative medicine. Delivered via methods like Major Autohemotherapy (MAH) or Ultraviolet Blood Irradiation (UBI), ozone is used by some clinicians for chronic infections, immune support, fatigue, and inflammation. The treatment has decades of clinical use in Europe and growing presence in US integrative medicine practices, but its evidence base is mixed and the FDA does not approve ozone for medical use. This guide explains what ozone IV therapy actually is, the protocols, what the evidence supports, costs, safety considerations, and how to evaluate providers if you're considering it.

What ozone therapy is

Ozone (O3) is a highly reactive form of oxygen with three atoms instead of the two in the oxygen we breathe. It's a strong oxidizer that, in controlled medical doses, is proposed to trigger a beneficial oxidative response in the body - stimulating antioxidant defense systems, improving oxygen delivery to tissues, and modulating immune function.

In ozone therapy, medical-grade ozone is generated on-site from medical oxygen using a specialized device. The ozone is mixed with the patient's blood outside the body, then returned. Ozone is never inhaled - inhalation is harmful to lungs.

How ozone IV therapy is delivered

Several methods exist, each with different protocols:

Major Autohemotherapy (MAH) is the most common. A volume of the patient's blood (typically 100-200ml) is drawn, mixed with ozone in a sterile container, then returned via IV. The whole process takes 30 to 45 minutes.
Minor Autohemotherapy uses a smaller blood volume and is administered intramuscularly rather than IV.
Ultraviolet Blood Irradiation (UBI) is often combined with ozone - the blood is exposed to UV light before being returned. Sometimes called "ozone-UBI" or "10-pass MAH" depending on protocol.
Direct IV ozone (rare in modern practice) involves IV administration of ozonated saline. Riskier than MAH and less commonly used.

Conditions it's used for

Practitioners use ozone IV therapy for a wide range of conditions, with varying levels of evidence:

Chronic Lyme disease and co-infections - common use case in integrative medicine
Chronic viral infections (herpes, hepatitis C, EBV reactivation)
Chronic fatigue and post-viral syndromes
Autoimmune conditions (rheumatoid arthritis, multiple sclerosis)
Cancer adjunct (alongside conventional treatment, not as a replacement)
Wound healing (particularly diabetic ulcers)
Athletic recovery and anti-aging protocols (more speculative)

The evidence - what's supported vs speculative

The clinical evidence for ozone therapy is genuinely mixed. There are some randomized controlled trials supporting use in specific conditions: peripheral artery disease, diabetic foot ulcers, certain orthopedic injections, and as a wound treatment. European clinicians have used ozone for decades with reasonable safety data, particularly in Italy, Germany, and Cuba.

For the popular wellness applications - chronic Lyme, chronic fatigue, autoimmune conditions, general immune support - the evidence is much weaker. Many small studies exist but lack rigor. Patient anecdotes are abundant but unverified. The FDA has not approved ozone therapy for any medical condition, and the American Cancer Society explicitly cautions against ozone for cancer treatment.

If you're considering ozone therapy, be appropriately skeptical of strong claims. A practitioner saying "ozone cures Lyme" should raise concern; one saying "ozone may help as part of a broader protocol while we work on the underlying condition" is more credible.

Cost

Ozone IV therapy is expensive relative to standard vitamin IVs:

Single MAH session: $200 to $400
10-pass MAH protocol (more aggressive treatment): $400 to $700 per session
Treatment series (often 6-10 sessions for chronic conditions): $2,000 to $7,000+ total
UBI add-on: typically $50 to $150 on top of MAH pricing

Insurance does not cover ozone therapy in the US.

Safety and contraindications

Ozone IV therapy carries real risks that vitamin IV therapy doesn't. The main concerns include hemolysis (red blood cell breakdown) at high doses, oxidative stress beyond beneficial levels in patients with G6PD deficiency, air embolism risk if administered improperly, and Herxheimer-like reactions in patients with chronic infections.

Absolute contraindications include G6PD deficiency, severe favism, pregnancy, recent heart attack, active hyperthyroidism, and ozone allergy (rare but documented).

This is genuinely a procedure where provider expertise matters enormously. Look for practitioners with formal ozone training (the American Academy of Ozonotherapy, or European certification programs), proper sterile technique, experience with your specific condition, and willingness to monitor lab work over time. A wellness lounge that recently added "ozone" to their menu is not the same as a clinic with years of dedicated ozone experience.

Finding a provider

Ozone therapy isn't typically offered at standard wellness IV clinics. You'll need to look for integrative medicine, functional medicine, or naturopathic practices that specifically offer it. Use the screening questions in our how to choose an IV therapy clinic guide, and add ozone-specific questions: what training does the practitioner have, what equipment do they use, what protocols, and what's their experience with your specific condition.

For more on the bioavailability arguments behind IV therapy generally, see our IV therapy vs oral supplements guide - though those arguments don't apply to ozone since there's no oral equivalent.

Considering ozone IV therapy? Discuss it with a physician you trust before pursuing it. Browse integrative medicine providers in your city → or use our 60-second matching quiz for general IV therapy options.

What ozone therapy actually is

Ozone (O3) is a three-atom oxygen molecule, the same gas that creates that sharp smell after a thunderstorm. In a medical context, "ozone IV therapy" almost always refers to major autohemotherapy (MAHT), a procedure in which 60 to 200 ml of a patient's own blood is drawn into a specialized vacuum glass container, mixed with a measured concentration of medical ozone gas, and then reinfused back into the same vein. The blood acts as the carrier; the ozone itself is never pushed directly into the bloodstream as a free gas. Direct IV ozone gas infusion exists as a fringe practice but is banned or strongly discouraged in most jurisdictions because of the risk of venous gas embolism.

You will also encounter related ozone protocols: rectal ozone insufflation (used heavily in Europe and Cuba), ozonated saline drips, ozonated water, and intra-articular ozone injections for joint pain. Marketing claims in 2026 typically center on chronic infections (Lyme, viral reactivations), autoimmune disease, adjunctive cancer care, post-COVID fatigue, and "cellular longevity." Modern ozone therapy traces its medical origins to Germany in the 1950s, where Dr. Hans Wolff opened the first ozone therapy school in 1953 and Dr. Joachim Hansler developed the first precise medical ozone generator in 1957 to 1958. Regulatory status today varies dramatically by country.

FDA position and US legal status (this is the critical section)

This section matters more than any other in this guide, because the regulatory reality is often glossed over in clinic marketing.

The US Food and Drug Administration does not approve medical ozone for any indication, in any form, for any patient. The FDA's longstanding position, restated repeatedly since 1976 and codified in 21 CFR 801.415, is blunt: ozone is "a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy." The agency further prohibits the marketing of any device that generates ozone at concentrations meant for human therapeutic use without an approved indication. There are no FDA-cleared ozone generators for IV or systemic therapy.

Despite this, ozone IV therapy is openly practiced in hundreds of US functional medicine, integrative oncology, and longevity clinics. These practices operate in a regulatory gray zone built on the "practice of medicine" doctrine, which lets licensed physicians use off-label or unapproved interventions if they take personal responsibility. State medical boards have disciplined MDs and DOs over ozone administration, particularly when accompanied by cancer-cure claims or following patient injury.

Documented patient deaths and serious injuries directly attributable to ozone therapy do exist in the medical literature, including case reports of cerebral gas embolism, multifocal ischemic stroke, pulmonary embolism, and at least one published case in The American Journal of Forensic Medicine and Pathology of an unexpected death during oxygen-ozone treatment. Practitioners point to decades of European safety data when performed correctly. The FDA has not changed its position in light of that data.

What the evidence actually shows

The honest picture is mixed, and it differs sharply depending on whether ozone is applied locally or systemically.

Wound healing (topical and local ozone): There is published clinical evidence supporting ozonated oil and gas bagging in diabetic foot ulcers and chronic non-healing wounds. This is the strongest area of the evidence base.
Dental applications: Topical ozone has moderate evidence for early carious lesions and certain endodontic uses, and is part of mainstream dentistry in some European countries.
Knee osteoarthritis (intra-articular injection): Several small randomized controlled trials, including a 2024 to 2025 double-blind dose-comparison trial published in Advances in Rheumatology, found that 20 to 40 microgram per milliliter intra-articular ozone produced statistically significant pain and function improvement versus oxygen control. Another 2024 trial compared oxygen-ozone to hyaluronic acid with broadly similar outcomes. These are short-term, small-sample studies, but the signal is real.
Systemic disease (chronic Lyme, autoimmune disease, cancer): The evidence is weak. Most published systemic-ozone studies are small, uncontrolled, single-center, or come from a handful of Italian, German, and Cuban groups with overlapping authorship and obvious conflicts of interest. A 2014 Cureus systematic review of autohemotherapy for urticaria and eczema and a 2016 evidence-classification paper in Ozone: Science and Engineering both concluded that protocol heterogeneity and small sample sizes prevent any high-confidence recommendation.
COVID-19: Several small studies appeared during the pandemic. None produced quality evidence of meaningful clinical benefit, and the WHO and major medical societies did not adopt ozone into any treatment guideline.
Anti-aging and longevity: No quality human evidence. Marketing claims here are essentially mechanistic speculation.

The honest summary: there are isolated medical indications, mostly local and not IV, where the research signal is real. The systemic IV ozone story marketed to chronic disease and longevity patients has claims that significantly outpace the evidence.

How major autohemotherapy is performed

A trained physician draws 60 to 200 ml of venous blood into a sealed, evacuated medical-grade glass bottle containing anticoagulant. A measured volume of medical ozone gas, typically dosed at 10 to 80 micrograms per milliliter (commonly 20 to 50 mcg/ml), is added from a calibrated medical ozone generator. The bottle is gently rolled or rocked to allow the ozone to react with the blood. The treated blood is then reinfused into the same vein, usually under gravity drip, over roughly 15 to 30 minutes. Total procedure time runs 30 to 60 minutes.

Three equipment details matter for safety:

The generator must be a medical-grade ozone unit producing a precise oxygen-ozone mixture. Industrial, spa, or "air purifier" ozone generators are absolutely not interchangeable. They can produce nitrogen oxides and uncontrolled concentrations.
The blood container must be glass, because ozone degrades most plastics and silicone, leaching contaminants.
Direct IV ozone gas push (skipping the autohemotherapy step) has been linked to multiple published deaths from venous gas embolism. Documented cerebral and pulmonary embolism cases exist even at small volumes.

Sterilization of reusable components and single-use tubing are non-negotiable. Sepsis outbreaks from contaminated equipment have been reported in the clinical literature.

What ozone IV therapy costs (2026)

In the US in 2026, single-session major autohemotherapy typically runs $250 to $500 at functional medicine and integrative oncology clinics. Multi-session packages are the norm, with eight to ten session series commonly priced at $2,000 to $5,000. Some clinics bundle ozone with high-dose vitamin C IV, glutathione push, or ultraviolet blood irradiation, pushing per-visit totals above $600.

Insurance coverage is effectively zero in the US. Because the FDA does not approve ozone for any medical indication, there is no procedure code that commercial insurers, Medicare, or Medicaid will reimburse, and HSA or FSA approval is unreliable. German statutory health insurance similarly stopped reimbursing ozone therapy as of December 11, 2020. Availability is concentrated in functional medicine practices, integrative oncology centers, and a small number of MD-led wellness clinics in major metro areas.

Side effects, contraindications, and serious risks

Common, mild effects include chest tightness, transient lightheadedness, a metallic taste, and post-treatment fatigue. Some practitioners label fatigue, flu-like symptoms, and joint aches in the 24 hours after treatment as a "Herxheimer reaction" or "die-off response." This label is mechanistically unproven in the context of ozone.

Serious risks documented in the peer-reviewed medical literature include:

Venous and arterial gas embolism, particularly with direct IV gas administration. Multiple fatal and near-fatal case reports exist, including cerebral gas embolism with multifocal ischemic stroke (published in 2024 in Frontiers in Neurology).
Sepsis from contaminated generators, tubing, or reused glass containers.
Hemolysis when ozone concentrations exceed safe ranges or when patients have erythrocyte fragility.
Anaphylactoid reactions and citrate-related reactions from anticoagulant in the collection bottle.
Pulmonary edema and pulmonary embolism, including a 2019 Pain Physician case report of suspected fatal pulmonary embolism following oxygen-ozone treatment for low back pain.
A widely cited German surveillance summary covering 1975 to 1983 documented six deaths and multiple cases of paraplegia, gas embolism, MI, and stroke linked to ozone administration over that period.

Clear contraindications include G6PD deficiency (risk of severe hemolysis), hyperthyroidism, pregnancy, active hemorrhage, recent myocardial infarction, severe anemia, thrombocytopenia, and known ozone hypersensitivity. Patients with significant cardiovascular disease should not pursue ozone therapy without input from their cardiologist.

Related on TheDripMap

How to evaluate an ozone therapy provider (if you proceed)

The vetting bar for ozone is much higher than for a basic hydration drip. If you are determined to proceed, demand all of the following.

Physician administration. The provider should be an MD or DO with formal ozone training, ideally certification from the American Academy of Ozonotherapy (AAO), the International Scientific Committee of Ozone Therapy (ISCO3), or a European body such as the German Medical Society for Ozone Therapy. RN- or naturopath-only ozone clinics are a red flag.
Medical-grade generator. Ask the brand and model. Reputable units include Herrmann, Zotzmann, and Longevity. Refuse if they cannot or will not tell you.
Major autohemotherapy only. Refuse any "direct IV ozone push." This is the protocol associated with documented deaths.
Glass collection bottle, single-use tubing, written sterilization protocol.
Vital signs monitoring during the procedure, IV access by trained staff, and on-site emergency equipment.
Informed consent that explicitly states FDA non-approval, lists the documented serious adverse events, and is signed before payment.
Honest claims. A practitioner who promises ozone will cure cancer, MS, ALS, autism, or chronic Lyme is making claims the evidence does not support. Walk out.

Skip ozone entirely if you have G6PD deficiency, cardiovascular disease, severe anemia, are pregnant, or are taking anticoagulants without specialist clearance. Skip it if the practitioner refuses to discuss FDA status candidly.

The honest reality is that ozone therapy in the US sits in a regulatory gray zone for a defensible reason: the safety and efficacy data is genuinely mixed, with a few real local indications surrounded by a much larger universe of marketing-driven systemic claims. For most consumers chasing "energy" or "longevity," better-evidenced and lower-risk wellness protocols exist. For chronic-disease patients considering it as adjunctive care, coordinate with your primary specialist before the first session, not after.